BVT Aktienanleihe OMV 27.06.2025/ DE000VM79F00 /
13/11/2024 19:42:06 | Chg.-0.410 | Bid10:00:00 | Demandez à10:00:00 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
97.970EUR | -0.42% | 97.950 Bid taille: 500,000 |
98.050 Ask la taille: 500,000 |
OMV AG | 40.00 EUR | 27/06/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
17/06/2009
Joint press release from OMV Aktiengesellschaft, Daimler AG, The
Linde Group and the State of Baden-...
GlobeNewswire
09/06/2009
Pilot test shows: Less CO2 emissions with new diesel from renewable
energy sources
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page